Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Smart Inhalers Market Worth USD 191 Million by 2022 - Analysis, Technologies & Forecasts Report 2014-2022 - Vendors: Propeller Health, Novartis, Vectura Group - Research and Markets

Research and Markets
Posted on: 01 Nov 16

Research and Markets has announced the addition of the "Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" report to their offering.

A new report, "Smart Inhalers Market by Product, Indication, and End User -Global Opportunity Analysis and Industry Forecast, 2014 -2022",states that the global smart inhalers market was $5.8 million in 2015 and is expected to reach $191 million by 2022, growing at a CAGR of 63.3% from 2016 to 2022. The inhalers segment captured majority share in 2015, whereas nebulizers segment is projected to grow at fastest CAGR of 64.1% during the forecast period. North America, which accounted for around two-fifths share in 2015, is expected to maintain its lead throughout.

Smart inhalers promote adherence to inhalers and also send timely reminders to patients to take their inhaler dose at the required time due to which it has emerged as a novel approach in asthma and COPD management. The major factors that drives the smart inhalers market include worldwide growth in population susceptible to indoor air pollutants, inclination of patients towards digitalized medical devices for monitoring daily medication doses, and rise in prevalence of asthma and COPD.

Companies Mentioned:

  • Adherium Limited
  • Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
  • Propeller Health
  • Cohero Health, LLC
  • OPKO Health, Inc. (Inspiro Medical Ltd.)
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Vectura Group plc

Report Structure:

CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW

CHAPTER 4 SMART INHALERS MARKET, BY PRODUCT, 2014-2022

CHAPTER 5 SMART INHALERS MARKET, BY INDICATION, 2014-2022

CHAPTER 6 SMART INHALERS MARKET, BY END USER, 2014-2022

CHAPTER 7 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022

CHAPTER 8 COMPANY PROFILES

For more information about this report visit http://www.researchandmarkets.com/research/64wjjd/smart_inhalers

View source version on businesswire.com: http://www.businesswire.com/news/home/20161101005981/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.